SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-052080
Filing Date
2024-06-12
Accepted
2024-06-12 16:05:07
Documents
14
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0207646-6k_xtlbio.htm 6-K 13911
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL AND EXTRAORDINAR ea020764601ex99-1_xtlbio.htm EX-99.1 230195
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S ANNUAL A ea020764601ex99-2_xtlbio.htm EX-99.2 29164
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHARE HOLDERS WITH RESPECT TO TH ea020764601ex99-3_xtlbio.htm EX-99.3 1327
5 GRAPHIC ex99-1_001.jpg GRAPHIC 3192
6 GRAPHIC ex99-1_002.jpg GRAPHIC 4865
7 GRAPHIC ex99-1_003.jpg GRAPHIC 6535
8 GRAPHIC ex99-1_004.jpg GRAPHIC 4972
9 GRAPHIC ex99-1_005.jpg GRAPHIC 7142
10 GRAPHIC ex99-1_006.jpg GRAPHIC 3830
11 GRAPHIC ex99-1_007.jpg GRAPHIC 5219
12 GRAPHIC ex99-2_001.jpg GRAPHIC 3192
13 GRAPHIC ex99-3_001.jpg GRAPHIC 983026
14 GRAPHIC ex99-3_002.jpg GRAPHIC 620941
  Complete submission text file 0001213900-24-052080.txt   2539238
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 241038395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)